Literature DB >> 9393790

The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate.

M Akkoyunlu1, A Melhus, C Capiau, O van Opstal, A Forsgren.   

Abstract

The nonacylated form of protein D (PDm) of Haemophilus influenzae has been shown to induce the production of antibodies that are bactericidal to homologous and heterologous nontypeable H. influenzae (NTHi) strains. In this study, immunization of rats with lipoprotein D (LPD) induced higher levels of anti-protein D immunoglobulin G and A serum antibodies than immunization with PDm, and the bactericidal activities of sera from LPD-immunized rats were greater than those of sera from PDm-immunized rats. Immunization with LPD or PDm did not prevent the development of acute otitis media (AOM) when rats were challenged with 10(4) CFU of an NTHi strain. However, on the eighth day of bacterial challenge, 50% (5 of 10) of LPD-immunized rats had recovered from otitis media and 30% (3 of 10) had negative middle ear cultures, whereas only 30% (3 of 10) of PDm-immunized rats had recovered, though none was culture positive. Immunization with an inactivated homologous bacterial strain elicited 70% protection (i.e., 7 of 10 rats) in the rat otitis media model. LPD and PDm were also conjugated to the H. influenzae type b (Hib) capsular polysaccharide, polyribosyl ribitol phosphate (PRP), to test protein D-conjugated PRP vaccine's potential for protection against Hib infection. When two LPD-conjugated and two PDm-conjugated PRP vaccines, each containing a different protein concentration, and a tetanus toxoid-conjugated vaccine (ACT-HIB) were tested in the experimental model of rat otitis induced with a Hib strain (Minn A), both of the LPD-conjugated and one of the PDm-conjugated vaccines induced significant protection from AOM, the level of protection being highest in animals given the vaccine with the highest LPD content. Sera from these rats also manifested the highest anti-PRP and anti-LPD antibody levels and the highest bactericidal activities against a Hib strain and an NTHi strain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393790      PMCID: PMC175723          DOI: 10.1128/iai.65.12.5010-5016.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Biological activity of serum antibodies to a nonacylated form of lipoprotein D of Haemophilus influenzae.

Authors:  M Akkoyunlu; H Janson; M Ruan; A Forsgren
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

2.  Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates.

Authors:  R S Munson; J L Shenep; S J Barenkamp; D M Granoff
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

3.  Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b.

Authors:  B A Green; T Quinn-Dey; G W Zlotnick
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

4.  Human antibody response to individual outer membrane proteins of Haemophilus influenzae type b.

Authors:  M R Loeb; D H Smith
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

5.  Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease.

Authors:  P A Gulig; G H McCracken; C F Frisch; K H Johnston; E J Hansen
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

6.  Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b.

Authors:  R S Munson; D M Granoff
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Characterization of Haemophilus influenzae isolated from patients with otitis media.

Authors:  H Dabernat; C Delmas; C Rich; V Livrelli; B Joly
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

8.  Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae.

Authors:  D M Musher; K R Kubitschek; J Crennan; R E Baughn
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

9.  Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.

Authors:  H E Gnehm; S I Pelton; S Gulati; P A Rice
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

10.  Protection by serum antibodies in experimental nontypable Haemophilus influenzae otitis media.

Authors:  S J Barenkamp
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

View more
  8 in total

1.  Mitogenicity of the recombinant mycobacterial 27-kilodalton lipoprotein is not connected to its antiprotective effect.

Authors:  Avi-Hai Hovav; Liuba Davidovitch; Gabriel Nussbaum; Jacob Mullerad; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

2.  Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection.

Authors:  L O Bakaletz; B J Kennedy; L A Novotny; G Duquesne; J Cohen; Y Lobet
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

3.  Identification of a Haemophilus influenzae 5'-nucleotidase protein: cloning of the nucA gene and immunogenicity and characterization of the NucA protein.

Authors:  R J Zagursky; P Ooi; K F Jones; M J Fiske; R P Smith; B A Green
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

4.  Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge.

Authors:  B J Kennedy; L A Novotny; J A Jurcisek; Y Lobet; L O Bakaletz
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

5.  Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx.

Authors:  Jennelle M Kyd; Allan W Cripps; Laura A Novotny; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

6.  The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection.

Authors:  Avi-Hai Hovav; Jacob Mullerad; Liuba Davidovitch; Yolanta Fishman; Fabiana Bigi; Angel Cataldi; Herve Bercovier
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  Pneumococcal Haemophilus influenzae protein D conjugate vaccine induces antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein D.

Authors:  Maija Toropainen; Anna Raitolehto; Isabelle Henckaerts; Dominique Wauters; Jan Poolman; Pascal Lestrate; Helena Käyhty
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

8.  A biphasic epigenetic switch controls immunoevasion, virulence and niche adaptation in non-typeable Haemophilus influenzae.

Authors:  John M Atack; Yogitha N Srikhanta; Kate L Fox; Joseph A Jurcisek; Kenneth L Brockman; Tyson A Clark; Matthew Boitano; Peter M Power; Freda E-C Jen; Alastair G McEwan; Sean M Grimmond; Arnold L Smith; Stephen J Barenkamp; Jonas Korlach; Lauren O Bakaletz; Michael P Jennings
Journal:  Nat Commun       Date:  2015-07-28       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.